Roswell Park Research Debunks Perceived Benefits of Overweight/Obesity in Lung Cancer Patients
Obesity is associated with a higher risk of developing at least 13 types of cancer — and worse outcomes after diagnosis. But lung cancer seems to be an exception: Studies have shown that patients with a high body mass index (BMI) experience a lower risk of disease recurrence and longer... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 8, 2024 Category: Pharmaceuticals Tags: TRI Source Type: news
Medicare Can Cover Anti-Obesity Drugs for Heart Disease -- But at What Cost?
(MedPage Today) -- On March 8, 2024, FDA approved Wegovy (semaglutide) to treat cardiovascular disease risks -- heart attack, stroke, and death -- for obese or overweight adults with a history of cardiovascular disease, making it the first... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - April 8, 2024 Category: Primary Care Source Type: news
WHOLE PERSON INTEGRATIVE EATING ® Launches New Podcast, "The Healing Secrets of Food Revealed," to Provide Science-Backed Weight-Loss Wisdom
Adding scientifically sound strategies to the weight-loss conversation AUSTIN, Texas, April 8, 2024 /PRNewswire-PRWeb/ -- WHOLE PERSON INTEGRATIVE EATING®, the breakthrough program that identifies and treats the root causes of overeating and overweight, is excited to announce the launch... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 8, 2024 Category: Pharmaceuticals Tags: PDT Source Type: news
How anti-obesity medications can help with surgery
Yale surgeons discuss the potential benefits of taking anti-obesity medications before and sometimes after total joint replacement or bariatric surgery. (Source: Yale Science and Health News)
Source: Yale Science and Health News - April 8, 2024 Category: Universities & Medical Training Source Type: news
Actually, It ’ s OK to Slouch
One of the latest and surprising findings in the field of physical therapy is that slouching is not as bad as we think it is. Certain researchers have gone so far as to say that the conventional fear mongering regarding poor posture can actually be more harmful than slouching itself. Undoing over a century’s worth of public health messaging about the evils of poor posture—let alone the custom of elders telling youngsters to “sit up straight”—will be a monumental task.
[time-brightcove not-tgx=”true”]
I know because I’ve spent the better part of a decade researching ...
Source: TIME: Health - April 8, 2024 Category: Consumer Health News Authors: Beth Linker Tags: Uncategorized freelance Source Type: news
Prior Anti-Obesity Drug Use Curbs Weight Loss on Semaglutide Prior Anti-Obesity Drug Use Curbs Weight Loss on Semaglutide
Patients who were overweight or obese lost more weight taking semaglutide if they hadn ' t previously taken another anti-obesity medication.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 8, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Do Adults With Obesity Feel Pain More Intensely? Do Adults With Obesity Feel Pain More Intensely?
Adults with excess weight or obesity reported higher pain levels, emphasizing the need to address obesity in pain management, according to a systematic review and meta-analysis.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 8, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Gut Bacteria's Influence on Obesity Differs in Men and Women Gut Bacteria's Influence on Obesity Differs in Men and Women
Different bacterial species affect the onset and development of obesity in men vs women.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - April 8, 2024 Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news
Weight-loss medicines: Biocon eyes a $100 billion jackpot with weighty pivot
Weight-loss drugs: Biocon Ltd. is shifting focus to anti-obesity therapies as patents for key medications expire, leading to a surge in generic supply. The Bengaluru-based company secured UK approval for the first generic version of liraglutide injectible, positioning itself as a leader in this evolving market. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 8, 2024 Category: Pharmaceuticals Source Type: news
Semaglutide Beneficial in HFpEF Patients With Diabetes Semaglutide Beneficial in HFpEF Patients With Diabetes
In patients with HFpEF and obesity, symptom reduction and weight loss provided by semaglutide extends to those with diabetes, suggest new data from the STEP-HFpEF DM trial.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - April 8, 2024 Category: Internal Medicine Tags: Cardiology Source Type: news
Wegovy Helps HFpEF Patients With Diabetes Mellitus
(MedPage Today) -- ATLANTA -- Weight loss and heart failure benefits with semaglutide (Wegovy) extended to patients with obesity-related heart failure with preserved ejection fraction (HFpEF) who have type 2 diabetes, the STEP-HFpEF DM trial showed... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 7, 2024 Category: Cardiology Source Type: news
UltraCon: How reliable is POCUS for pancreatic imaging?
AUSTIN, TX – Point-of-care ultrasound (POCUS) isn’t typically used for imaging the pancreas, but perhaps that should change, according to a presentation given April 7 at UltraCon.
In her talk, Alice Lee, MD, from Stanford University in California highlighted findings on how POCUS can be a reliable tool for pancreatic imaging, whether performed by experienced or novice sonographers.
“One of the big implications of pancreatic POCUS is the way that we put imaging in the hands of a provider who’s really managing the patient, whether it’s the gastroenterologist or the primary care physician,” Lee said.
Alice Lee,...
Source: AuntMinnie.com Headlines - April 7, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Ultrasound Gastrointestinal Radiology Source Type: news
Study shows Wegovy easing heart failure symptoms for patients with diabetes
Wegovy, the blockbuster weight-loss medication from Novo Nordisk A/S, eased heart failure symptoms for patients with diabetes in the latest large trial to support use of the drug to treat health conditions linked to obesity. Patients who took Wegovy reported less fatigue, less leg swelling, were…#novonordiskas #novo #danish #jama (Source: Reuters: Health)
Source: Reuters: Health - April 6, 2024 Category: Consumer Health News Source Type: news
Wegovy ’s heart benefits are not just linked with weight loss, new study suggests
People with obesity-related heart failure and diabetes can get substantial heart-health benefits from weight-loss drug Wegovy, even if they don’t shed many pounds on the medication, according to new research. (Source: Reuters: Health)
Source: Reuters: Health - April 6, 2024 Category: Consumer Health News Source Type: news
Gestational Weight Gain Below IOM Recommendation Safe in Obesity
FRIDAY, April 5, 2024 -- Gestational weight gain below the current U.S. Institute of Medicine (IOM) recommendation is safe for pregnancies with obesity, according to a study published online March 28 in The Lancet.Kari Johansson, Ph.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 5, 2024 Category: Pharmaceuticals Source Type: news
